Additive Works joins Altair Partner Alliance

Officials from the Altair Partner Alliance (APA) announce the addition of Additive Works’ Amphyon to its software offering.

Amphyon is a simulation-driven process software for powder bed-based, laser beam melting additive manufacturing (AM) processes.

It allows for automatic optimization of part orientation as well as a build-up process simulation and the adaption of process parameters to improve part quality and process stability.

By integrating fast numerical process analysis and simulation into the process chain, surface quality and shape accuracy can be increased without the need for further action by the user.

Amphyon consists of several modules which support the pre-processing and enhance the process itself.

Amphyon and its modules focus on: helping designers learn how to deal with AM and its issues, helping researchers study process physics by numerical simulation, and helping production optimize pre-processing and build data in a few steps.

www.altairhyperworks.com/apa; www.additive.works

3D Systems names rms first certified partner

3D Systems’ certified partner program for medical device additive manufacturing (AM) companies named rms Co. as its first partner to accelerate precision healthcare offerings. Joining the quality supply network allows rms to focus on design, development, and manufacturing of medical implants using 3D Systems’ direct metal printing (DMP) technology.

This partnership combines the equipment, process, and materials expertise of 3D Systems with the manufacturing expertise of rms, enabling medical device companies to source development and production of FDA-cleared medical devices under one roof.

As part of certification process, rms has validated its ProX DMP 320 printer, the materials, and critical support processes. The company is already engaged with several orthopedic customers to develop and manufacture implants using titanium powder.

www.3dsystems.com; www.rmsmachining.com

3D imaging, printing improving clinical trials

Cardiovascular medical device developers and clinicians are turning to Materialise’s 3D printing software and services to improve clinical trial outcomes and efficiency, bringing innovations to market.

Materialise 3D imaging and printing solutions allow surgeons and device companies to analyze and select ideal patients for clinical trials, based on their anatomy. Medical professionals can use patient-specific, 3D-printed anatomical models to develop surgical plans and workflows to prepare for and treat complex cases.

For medical device developers, 3D printing also provides a more efficient process for prototype and manufacturing, allowing developers to create trial-ready devices, either at the point of care or through Materialise’s 3D-printing services.

www.materialise.com